[ ZappRx raises $25M in Series B ]
ZappRx has raised $25 million in Series B funding.
Founded in 2012, ZappRx is a digital health company that is modernizing and simplifying the way specialty drugs are managed. The company solves a unique dilemma in the prescription medication industry for doctors and pharmacists who treat conditions like oncology and pulmonology by getting rid of the paperwork. Many pharmacies still use fax or phone to transfer medical prescription information from the doctor, delaying the process and making mistakes more likely. ZappRx solves that by automating the via an app which can process the information in real-time.
The new funding will help the company expand in a fast-growing.
|Founder / CEO||Zoe Barry|
|Investors||Qiming Venture Partners|
|Previous Investors||Atlas Venture|
|Life Sciences Angel Network|